HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $355,000 | +14.5% | 20,000 | 0.0% | 0.01% | +8.3% |
| Q3 2019 | $310,000 | -9.9% | 20,000 | 0.0% | 0.01% | -7.7% |
| Q2 2019 | $344,000 | +6.8% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $322,000 | +9.9% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $293,000 | -90.5% | 20,000 | -88.2% | 0.01% | -87.0% |
| Q3 2018 | $3,089,000 | +7.7% | 170,000 | 0.0% | 0.10% | -6.5% |
| Q2 2018 | $2,868,000 | -13.9% | 170,000 | 0.0% | 0.11% | -23.0% |
| Q1 2018 | $3,330,000 | -3.3% | 170,000 | 0.0% | 0.14% | -5.4% |
| Q4 2017 | $3,444,000 | +16.6% | 170,000 | 0.0% | 0.15% | +15.7% |
| Q3 2017 | $2,953,000 | -75.7% | 170,000 | -82.1% | 0.13% | -74.3% |
| Q2 2017 | $12,176,000 | – | 949,800 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |